Patent 7378102 was granted and assigned to Nippon Zoki Pharmaceutical Co., Ltd. on May, 2008 by the United States Patent and Trademark Office.
The present invention relates to a diclofenac sodium oral pharmaceutical containing diclofenac sodium, a nonionic surfactant, a cholic acid derivative as an absorption promoting agent, and a glycerin or a glycol.